Lorna Goodwin
Senior Consultant
The Med-Tech industry is striving to create new technologies that deliver innovative, flexible and efficient diagnostic solutions for healthcare practitioners. It’s one of the largest, growing industries in the UK right now.
Claiming R&D Tax Relief for the development of these technologies can help re-coup a significant proportion of these costs. A recent study found that one in five (21%) innovation active engineering firms (including Med-Tech companies) are not taking advantage of the government’s R&D Tax Credit scheme, potentially missing out on over £10 billion of R&D funding each year.
Developing medical technologies can be a lengthy journey and the time it takes to get a product to market is notably longer than in other industries. This can be due to the large amount of legislation and regulations a med-tech product must adhere to, the clinical trials to prove the technology works, the process of receiving CE marking and getting buy-in from healthcare providers such as the NHS.
Claiming R&D Tax Relief for Med-Tech innovation during the development of your new technology allows you to recoup up to 33% of your eligible research and development expenditure as either Corporation Tax relief or a cash repayment.
The financial benefit of your claim can help fund the next stages of your development and maybe even accelerate the process of getting your product to market!
The first step to making your claim for R&D Tax Credit Relief for Med-Tech Innovation is to identify which activities are eligible for the HMRC schemes. Here are a few examples:
The average R&D Tax Credits claim for Med-Tech businesses is £68,000 per annum and the rapid developments within the industry means that claim values can range from thousands to millions.
At TBAT, we’ve helped a wide range of Med-Tech businesses make their R&D Tax Credit claims and have in-house industry experts that fully understand your technology.
Our team will deep-dive into your projects, identify all of the eligible R&D activity and expenditure to ensure you submit a maximised claim to HMRC.
Get your claim started with us by entering a few simple figures with our online R&D Tax Credit Calculator to work out how much your claim could be worth!
A detailed summary of the First-tier Tribunal’s decision in Realbuzz Group Ltd v HMRC (May 2025), focusing on the limits of HMRC’s discovery assessment powers in relation to R&D tax relief claims. We touch on key tribunal issues including the “hypothetical officer” test, the importance of adequate disclosure, and the legal protections available to taxpayers. The ruling offers important guidance for companies claiming R&D tax credits and clarifies HMRC’s ability to revisit prior-year claims.
The May 2025 Research & Development Communication Forum (RDCF) returned to an in-person format for the first time since the pandemic. Held in a historic setting with a focus on open dialogue, the forum covered key updates from HMRC, including policy changes, operational performance, and ongoing efforts to improve the R&D claims process. In this article, we share updates from the RDCF and our reflections on what it all means for businesses and advisors moving forward.
Assists organisations in accessing research and development grant funding across a range of UK and EU schemes and industry sectors.
Get In Touch
Call 
Back
